Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study

Autor: Rodriguez, Carina A, Natukunda, Eva, Strehlau, Renate, Venter, Esme L, Rungmaitree, Supattra, Cunningham, Coleen K, Lalloo, Umesh, Kosalaraksa, Pope, HellstrÖm, Elizabeth, Liberty, Afaaf, McGrath, Eric J, Kaur, Meenu, Leisegang, Rory, Hindman, Jason T, Vieira, Vinicius A, Kersey, Kathryn, Cotton, Mark F, Rakhmanina, Natella, Gaur, Aditya H *
Zdroj: In The Lancet HIV May 2024 11(5):e300-e308
Databáze: ScienceDirect